Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.
Bäck S, Peränen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T, Voutilainen MH, Raasmaja A, Saarma M, Männistö PT, Tuominen RK.
Bäck S, et al. Among authors: raasmaja a.
Brain Behav. 2013 Mar;3(2):75-88. doi: 10.1002/brb3.117. Epub 2013 Jan 14.
Brain Behav. 2013.
PMID: 23532969
Free PMC article.